What We Do
We power the innovators shaping the future of pediatric health.
Move Founders + Startups
We give fast, credible pediatric evidence and adoption guidance without the hiring overhead.
Support Accelerators + Venture Studios
We help portfolio companies with expert pediatric insight for diligence, growth, and credibility.
Guide Investors + Funders
We provide independent pediatric product reviews to assess safety, fit, and adoption potential.
Equip Healthcare Innovators + Product Teams
We deliver expert roadmaps to test, adapt, and scale pediatric tools for research and clinical use.
Flat-Fee Pediatric Expertise, Delivered Fast
Services are customized to your team, flat-fee, with clearly defined deliverables—no hourly billing, no ambiguous scopes.
Pediatric Evidence Roadmap
$8k-10k • 2-3 weeks
Show proof with credible study design.
✓ Project Definition Meeting
✓ Roadmap PDF + readout
✓ Expert pediatric PhD consult
✓Study design plan (feasibility, pilot, or trial)
✓ Outcomes + recruitment strategy
✓ Ethical safeguards review
✓ Funding pathways to explore
Pediatric Adoption Roadmap
$8k-10k • 2-3 weeks
Validate clinical fit and adoption strategy.
✓ Project Definition Meeting
✓ Roadmap PDF + readout
✓ Expert pediatric PhD consult
✓ Workflow &+operational mapping
✓ Safety + development alignment
✓ Risk/benefit profile
✓ Adoption enablers + barriers
Integrated Roadmap
*Most Comprehensive*
$14k-16k • 4 weeks
Map proof and adoption in a single plan.
✔ Project Definition Meeting
✔ Roadmap PDF + readout session
✔ Expert pediatric PhD consult
✔ Comprehensive consultant team
✔ Evidence Roadmap deliverables
✔ Adoption Roadmap deliverables
✔ 12–18 month integrated action plan
✔ Team expert readout with expert team
✔ Prioritized milestones with timeline (clear sequence of next steps)
✔ Tailored resource + stakeholder recommendations (who/what to engage next)
The Clearview Advantage
Cras dictum id pharetra suspendisse adipiscing semper mi ipsum amet ante nibh velit cursus imperdiet mus suscipit felis ultricies consectetuer Maximus finibus lorem
Credibility = Fundability
70% of healthcare investors cite clinical validation as their top funding driver.1,2
Without it, companies systematically lose funding dollars, adoption, trust, and clinical impact. 3,4
Our doctoral-level experts give you investor-ready pediatric validation.
Fastrack Clinical Adoption
Approximately 60% of digital health pilots stall because of barriers like poor data readiness and mismatch to real-life workflow.5,6
Failed pilots waste $500K+ on average and stall market entry.6
We clear adoption barriers early so your product scales in real clinical use.
Impact Spotlights
Pediatric insight that works in the real world
Challenge: A pediatric team needed to evolve their chronic pain program for youth to fit youth with overlapping conditions and new science.
Our Impact: In less than three weeks, we guided updates to both parent and child content, ensuring inclusivity, developmental soundness, and behavioral science alignment.
Result: The program pivoted successfully and is now rolling out to more than 30 children’s hospitals across three continents.
Challenge: A digital health team building a pediatric VR device wasn’t sure which features would actually deliver value for kids managing symptoms.
Our Impact: We delivered strategic consultation to align the program with child development principles and optimize it for clinical and real-world fit.
Result: They sharpened strategy and successfully secured funding from an NIH-accelerator.
Challenge: A team building a pediatric resilience intervention needed expert input to refine strategy and ensure developmental and clinical soundness.
Our Impact: Clearview pediatric psychologists provided strategic consultation to align the program with child development principles and optimize it for clinical and real-world fit.
Result: The resilience intervention advanced with sharper strategy and stronger grounding in evidence-based pediatric psychology, sailing through the next funding phase and moving toward clinical adoption seamlessly.
What We Do
Provide pediatric PhD–level evidence and adoption guidance.
Deliver flat-fee, outcome-based roadmaps.
De-risk products for real-world use (kids, systems, funders).
Customize insights to your stage: early proof, adoption fit, or both.
What We Don’t Do
Deliver direct treatment or clinical care.
Replace your internal team—we enhance them.
Work on open-ended, hourly consulting with unclear scope.
Offer “one-size-fits-all” advice—we’re project-specific.
Footnotes
- Norden J., Clinical validation will save digital health’s reputation (STAT, Aug 16 2022).
- Khozin, AI in Drug Development: Clinical Validation and Regulatory Innovation Are Dual Imperatives, DIA Global Forum, June 2025
- Carroll AR, Hall M, Harris M, et al. Validation of 30-Day Pediatric Hospital Readmission Risk Prediction Models. JAMA Netw Open. 2025;8(2):e2459684. doi:10.1001/jamanetworkopen.2024.59684
- Digital Medicine Society, “Seeing the Bigger Picture: Unlocking Value for Payors and Investors,” The Playbook: Pediatric Digital Medicine, February 25, 2025, Digital Medicine Society (DiMe).
- Borges do Nascimento IJ, et al. “The global effect of digital health technologies on health workers’ competencies and health workplace: an umbrella review of systematic reviews and lexical-based and sentence-based meta-analysis.” The Lancet Digital Health, Vol. 5, No. 8, 2023, pp. e534–e544.
- Bata SA, Richardson T. Value of Investment as a Key Driver for Prioritization and Implementation of Healthcare Software. Perspect Health Inf Manag. 2018 Jan 1;15(Winter):1g. PMID: 29618963; PMCID: PMC5869444.
- Kurbatfinski S, Komanchuk J, Dosani A, Letourneau N. Validity, Reliability, Accessibility, and Applicability of Young Children’s Developmental Screening and Assessment Tools across Different Demographics: A Realist Review. Children (Basel). 2024 Jun 18;11(6):745. doi: 10.3390/children11060745. PMID: 38929324; PMCID: PMC11201752.
- Tran A., Valo P., Rouvier C., et al. “Validation of the Computerized Pediatric Triage Tool, pediaTRI, in the Pediatric Emergency Department of Lenval Children’s Hospital in Nice: A Cross-Sectional Observational Study.” Frontiers in Pediatrics, vol. 10, 2022.
